Industries > Pharma > Global Neuromodulation Devices Report 2018-2028

Global Neuromodulation Devices Report 2018-2028

Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications

PUBLISHED: 09 April 2018
PAGES: 221
PRODUCT CODE: PHA0299

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE

The neuromodulation devices market is estimated to grow at a CAGR of 11.7% in the first half of the forecast period. The Spinal Cord Stimulation (SCS) submarket is estimated to account for 43.6% share of this market in 2018.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 221-page report you will receive 125 charts– all unavailable elsewhere.

The 221-page report provides clear detailed insight into the global neuromodulation devices market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Neuromodulation Devices market forecasts from 2018-2028

• This report also breaks down the revenue forecast for the global neuromodulation devices market by type:
• Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS)
• Vagus Nerve Stimulation (VNS)
• Sacral Nerve Stimulation (SNS)
• Gastric Electrical Stimulation (GES)
• Other Applications

This report discusses the market trends and lists the leading products/pipeline products of each submarket.

• This report provides individual revenue forecasts to 2028 for these regional and national markets:
• North America: the US and Canada
• Europe: France, Germany, Italy, U.K, Spain, Russia, Rest of Europe
• Asia-Pacific: Japan, China, India, Australia, South Korea and rest of Asia-Pacific
• Latin America: Brazil, Mexico, Rest of Latin America
• Rest of the World: Middle East, Africa

Global Neuromodulation Devices Report 2018-2028

Each regional market is further segmented by type of applications: Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications

• Our study gives qualitative analysis of the neuromodulation devices market. It discusses the factors that drive and restrain the neuromodulation devices market. This study also provides a SWOT and STEP analysis.

• Our study discusses the selected leading companies that are the major players in the neuromodulation devices industry:
• Medtronic
• Boston Scientific
• St Jude Medical (Abbott)
• Cyberonics (LivaNova)
• Stryker Corporation
• Nevro Corp.
• SetPoint Medical
• Functional Neuromodulation
• Neurotherapies Reset
• Wringless Implantable Stretchable Electronics (WISE)
• SceneRay
• Mindray

Visiongain’s study is intended for anyone requiring commercial analyses for the global neuromodulation devices market. You find data, trends and predictions.

Buy our report today Global Neuromodulation Devices Report 2018-2028: Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Neuromodulation Devices Report 2018-2028

    Download sample pages

    Complete the form below to download your free sample pages for Global Neuromodulation Devices Report 2018-2028

      Latest Pharma news

      Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

      The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

      12 April 2024

      READ

      Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034

      The global Inflammatory Bowel Diseases (IBD) Drugs market was valued at US$27.53 billion in 2023 and is projected to grow at a CAGR of 6.2% during the forecast period 2024-2034.

      11 April 2024

      READ

      Visiongain Publishes Female Health Tech Market Report 2024-2034

      The global Female Health Tech market was estimated to be valued at US$ 140.9 billion in 2034 and is expected to register a CAGR of 9.6% from 2024 to 2034.

      05 April 2024

      READ

      Visiongain Publishes Meningococcal Vaccines Market Report 2024-2034

      The global Meningococcal Vaccines market is projected to grow at a CAGR of 2.5% by 2034

      26 March 2024

      READ